HK1155742A1 - 二氫吲哚酮化合物、它們的製備方法以及包含它們的藥物組合物 - Google Patents

二氫吲哚酮化合物、它們的製備方法以及包含它們的藥物組合物

Info

Publication number
HK1155742A1
HK1155742A1 HK11110000.4A HK11110000A HK1155742A1 HK 1155742 A1 HK1155742 A1 HK 1155742A1 HK 11110000 A HK11110000 A HK 11110000A HK 1155742 A1 HK1155742 A1 HK 1155742A1
Authority
HK
Hong Kong
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
dihydroindolone
compounds
Prior art date
Application number
HK11110000.4A
Other languages
English (en)
Inventor
Jean-Claude Ortuno
Alexis Cordi
Jean-Michel Lacoste
Imre Fejes
Michael Burbridge
John Hickman
Alain Pierre
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1155742A1 publication Critical patent/HK1155742A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Storage Device Security (AREA)
  • Computer And Data Communications (AREA)
HK11110000.4A 2009-08-04 2011-09-22 二氫吲哚酮化合物、它們的製備方法以及包含它們的藥物組合物 HK1155742A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0903839A FR2948940B1 (fr) 2009-08-04 2009-08-04 Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
HK1155742A1 true HK1155742A1 (zh) 2012-05-25

Family

ID=41796204

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11110000.4A HK1155742A1 (zh) 2009-08-04 2011-09-22 二氫吲哚酮化合物、它們的製備方法以及包含它們的藥物組合物

Country Status (43)

Country Link
US (3) US8133889B2 (zh)
EP (1) EP2281822B1 (zh)
JP (2) JP5475588B2 (zh)
KR (1) KR101309101B1 (zh)
CN (1) CN101987848B (zh)
AP (1) AP2756A (zh)
AR (1) AR077510A1 (zh)
AU (1) AU2010203305B2 (zh)
BR (1) BRPI1003241A2 (zh)
CA (1) CA2710224C (zh)
CL (1) CL2010000804A1 (zh)
CO (1) CO6320143A1 (zh)
CU (1) CU23921B1 (zh)
CY (1) CY1113914T1 (zh)
DK (1) DK2281822T3 (zh)
EA (1) EA019481B1 (zh)
EC (1) ECSP10010380A (zh)
ES (1) ES2403227T3 (zh)
FR (1) FR2948940B1 (zh)
GE (1) GEP20125548B (zh)
HK (1) HK1155742A1 (zh)
HN (1) HN2010001537A (zh)
HR (1) HRP20130327T1 (zh)
IL (1) IL207183A (zh)
JO (1) JO2808B1 (zh)
MA (1) MA32184B1 (zh)
ME (1) ME01491B (zh)
MX (1) MX2010008557A (zh)
MY (1) MY183326A (zh)
NI (1) NI201000134A (zh)
NZ (1) NZ586993A (zh)
PE (1) PE20110206A1 (zh)
PL (1) PL2281822T3 (zh)
PT (1) PT2281822E (zh)
RS (1) RS52701B (zh)
SA (1) SA110310634B1 (zh)
SG (1) SG168499A1 (zh)
SI (1) SI2281822T1 (zh)
TW (1) TWI408138B (zh)
UA (1) UA105357C2 (zh)
UY (1) UY32801A (zh)
WO (1) WO2011015728A1 (zh)
ZA (1) ZA201005424B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948940B1 (fr) 2009-08-04 2011-07-22 Servier Lab Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3008411B1 (fr) * 2013-07-12 2015-07-03 Servier Lab Nouveau sel de la 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, sa preparation, et les formulations qui le contiennent
US10245270B2 (en) * 2013-07-12 2019-04-02 Les Laboratoires Servier Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing it
JP6156845B2 (ja) * 2014-03-04 2017-07-05 株式会社島津製作所 マトリックス支援レーザ脱離イオン化質量分析用マトリックス
FR3039401B1 (fr) * 2015-07-31 2018-07-13 Les Laboratoires Servier Nouvelle association entre le 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione et un inhibiteur de la tyr kinase du egfr
US10343991B2 (en) * 2016-11-02 2019-07-09 Council Of Scientific & Industrial Research C5, C6 substituted and/or fused oxindoles as anti-cancer agents and process for preparation thereof
JOP20200024A1 (ar) * 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
WO2019025554A1 (en) 2017-08-04 2019-02-07 Bayer Aktiengesellschaft 6-PHENYL-4,5-DIHYDROPYRIDAZIN-3 (2H) -ONE DERIVATIVES AS INHIBITORS OF PDE3A AND PDE3B FOR THE TREATMENT OF CANCER
CN113845524B (zh) * 2021-10-29 2023-11-07 四川农业大学 一种螺吡咯吲哚酮类化合物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0892248A (ja) * 1994-09-26 1996-04-09 Yamanouchi Pharmaceut Co Ltd インドリノン誘導体
CA2383623A1 (en) * 1998-08-04 2000-02-17 Sugen, Inc. 3-methylidenyl-2-indolinone modulators of protein kinase
TR200101860T2 (tr) * 1998-12-17 2001-12-21 F.Hoffmann-La Roche Ag Sikline bağlı kinaz inhibitörleri olarak 4-alkenil (ve alkinil) oksidoller
WO2001000814A2 (en) 1999-06-25 2001-01-04 Universität Zürich Hetero-associating coiled-coil peptides and screenign method therefor
CA2399358C (en) * 2000-02-15 2006-03-21 Sugen, Inc. Pyrrole substituted 2-indolinone protein kinase inhibitors
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
US6686362B2 (en) * 2001-12-27 2004-02-03 Theravance, Inc. Indolinone derivatives
US7012088B2 (en) * 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
US7105563B2 (en) * 2003-10-24 2006-09-12 Schering Aktiengesellschaft Indolinone derivatives and their use in treating disease-states such as cancer
US7378530B2 (en) * 2005-02-22 2008-05-27 Nereus Pharmaceuticals, Inc. Anti-cancer and anti-microbial 5-membered heterocyclic compounds
CN101389331A (zh) * 2005-12-29 2009-03-18 斯克里普斯研究学院 基于吲哚满酮的氨基酸衍生物的蛋白激酶抑制剂
FR2948940B1 (fr) 2009-08-04 2011-07-22 Servier Lab Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
SI2281822T1 (sl) 2013-04-30
CY1113914T1 (el) 2016-07-27
JP2013116908A (ja) 2013-06-13
JO2808B1 (en) 2014-09-15
KR101309101B1 (ko) 2013-09-16
FR2948940A1 (fr) 2011-02-11
PL2281822T3 (pl) 2013-06-28
GEP20125548B (en) 2012-05-25
US20120046287A1 (en) 2012-02-23
ECSP10010380A (es) 2011-03-31
ZA201005424B (en) 2011-04-28
US20110034460A1 (en) 2011-02-10
FR2948940B1 (fr) 2011-07-22
CU20100157A7 (es) 2012-03-15
NZ586993A (en) 2012-01-12
CN101987848B (zh) 2014-06-18
ME01491B (me) 2014-04-20
AP2010005343A0 (en) 2010-08-31
ES2403227T3 (es) 2013-05-16
SG168499A1 (en) 2011-02-28
EP2281822A1 (fr) 2011-02-09
EA019481B1 (ru) 2014-04-30
UY32801A (es) 2011-01-31
PE20110206A1 (es) 2011-04-09
US8541412B2 (en) 2013-09-24
AU2010203305A1 (en) 2011-02-24
BRPI1003241A2 (pt) 2012-04-10
CL2010000804A1 (es) 2011-08-26
CA2710224A1 (fr) 2011-02-04
US20130331380A1 (en) 2013-12-12
CN101987848A (zh) 2011-03-23
RS52701B (en) 2013-08-30
HRP20130327T1 (hr) 2013-05-31
DK2281822T3 (da) 2013-04-22
JP5475588B2 (ja) 2014-04-16
MY183326A (en) 2021-02-18
EA201001087A1 (ru) 2011-04-29
AP2756A (en) 2013-09-30
KR20110014116A (ko) 2011-02-10
PT2281822E (pt) 2013-02-27
NI201000134A (es) 2014-02-11
US8133889B2 (en) 2012-03-13
AR077510A1 (es) 2011-08-31
WO2011015728A1 (fr) 2011-02-10
US8653073B2 (en) 2014-02-18
MA32184B1 (fr) 2011-04-01
TWI408138B (zh) 2013-09-11
EP2281822B1 (fr) 2013-01-16
IL207183A0 (en) 2010-12-30
MX2010008557A (es) 2011-02-03
HN2010001537A (es) 2013-05-06
AU2010203305B2 (en) 2015-02-05
SA110310634B1 (ar) 2013-11-10
UA105357C2 (uk) 2014-05-12
CA2710224C (fr) 2013-01-08
TW201118092A (en) 2011-06-01
IL207183A (en) 2014-01-30
JP2011037848A (ja) 2011-02-24
CU23921B1 (es) 2013-07-31
CO6320143A1 (es) 2011-09-20
JP5538580B2 (ja) 2014-07-02

Similar Documents

Publication Publication Date Title
AP2014007774A0 (en) New pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
AP3050A (en) New Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions comprising them
AP3024A (en) New Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200704957B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
HK1155742A1 (zh) 二氫吲哚酮化合物、它們的製備方法以及包含它們的藥物組合物
IL200128A0 (en) New tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them
IL223872A (en) Pyrazoloquinoline derivatives and intermediates, process for preparation, use and pharmaceutical preparations and preparations containing them
IL217053A0 (en) Nanoparticulate candesarten cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them
IL218525A (en) Compounds 2,1 - Dihydro - 2 - Oxoquinoline Receptor Legendants 5 - 4ht Process for Preparing, Containing and Using Medical Preparations
PL2504331T3 (pl) Związek, jego nowe formy, zawierające je kompozycje farmaceutyczne i sposoby otrzymywania oraz zastosowanie
IL218044A (en) (Trihalophenyl – Methyl) –1) –Halophenyl –– 2Imidazolyl – Ethyl (–Sites, process for their preparation and pharmaceutical preparations containing them
EP2393361A4 (en) PHARMACEUTICAL QUALITY PHTHALAZINEDIONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL206885A0 (en) New chromene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200704955B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201000025B (en) New naphthalene compounds,a process for their preparation and pharmaceutical compositions containing them
ZA201106353B (en) Dihydrobenzoxathiazepine compounds,a process for their preparation and pharmaceutical compositions containing them
AP2010005304A0 (en) New 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them
HK1176355A1 (zh) 二氫-噁唑並苯並二氮雜䓬酮類化合物、製備它們的方法和包含它們的藥物組合物
AP2009004891A0 (en) New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201000024B (en) New naphthalene compounds,a process for their preparation and pharmaceutical compositions containing them
IL206884A0 (en) New piperidine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200704956B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
AP2010005327A0 (en) New chromene compounds, a process for their preparation and pharmaceutical compositions containing them.
HU0900383D0 (en) Nanoparticulate aprepitant compositions, process for the preparation thereof and pharmaceutical compositions containing them
HU0900381D0 (en) Nanoparticulate ezetimibe compositions, process for the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200801